Investors should expect more volatility as the second quarter gets underway — and they may want to start preparing for a recession, experts say. That means finding fortress stocks to protect their portfolios. Turmoil in the bank sector has renewed fears of an economic slowdown as financial institutions tighten lending conditions.
In keeping with his dividend theme, Bahnsen likes Gilead Sciences , which currently yields 3.6%. He also likes Merck and Johnson & Johnson , which yield 2.7% and 2.9%, respectively. "The models of these pharmaceutical companies are very friendly to dividend growth. They have a lot of recurring cash flow," he said. The first priority of that cash flow is research and development, or in the case of Merck, mergers and acquisitions, Bahnsen said.
This is just a link to a pay area of CNBC called CNBC Pro.
Buy index funds. Balance between cash, bonds and stocks to suit your risk tolerance. Ignore CNBC and everything else. All they care about is you clicking their links so they can sell ads.